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Abstracts / Pediatric Hematology Oncology Journal 1 (2016) S1eS33 S19Conﬁrmation of diagnosis in LAD-I requires demonstration of absence of
CD18 and associated alpha subunit of CD11a, CD11b, CD11c on ﬂow
cytometry. 4 of 6 patients had complete absence of the integrins. Differ-
ential diagnosis include Interleukin-1 receptor associated kinase deﬁ-
ciency, Hyper IgE syndrome and leukemoid reaction. The only corrective
treatment is hematopoietic stem cell transplantation. Reported survival in
a largest series is5 years after follow up was 75%. These patients die in
childhood if transplantation is not done and if the transplantation is car-
ried out before serious infections, the prognosis is very good.
LAD is a rare form of congenital immune deﬁciency to be suspected in a
child with delayed fall of umbilical cord, highWBC count with neutrophilia
and consanguineous marriage. High index of suspicion and early diagnosis
before infection sets in is important as mortality rate is high. Pseudomonas
was most common organism isolated in the present study.Figure 1. No correlation between serum ferritin and cardiac ironload.ĂRBC Disorders
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Background: Acquired aplastic anemia (AA) is a haematological emer-
gency in children and we have gained enormous knowledge about the
pathogenesis and immune mediated self-destruction of stem cells and
immunosuppressive therapy. Due to its rarity, we have limited data of this
entity, especially, its course and outcome in resource limited countries.
Patients and methods: The case records of children who had been diag-
nosed to have AA since 2002 at our centre were reviewed. The diagnosis of
AA was made in children with pancytopenia without organomegaly and
conﬁrmed by hypocellular bone marrow showing decreased expression of
all three hematopoietic lineages. Clinical ﬁndings including dysmorphism,
thumb abnormalities, congenital malformations and skin hyperpigmen-
tation were noted down. Mitomycin C induced chromosomal instability to
rule out Fanconi anaemia, Ham's test to look for paroxysmal nocturnal
haemoglobinuria and chromosomal analysis to look for complex karyo-
typic abnormalities seen in myelodysplastic syndrome were documented
in all patients.
After initial stabilization, the option of haematopoietic stem cell trans-
plantation (HSCT) was offered to all those who had matched related do-
nors. If not, immunosuppressive therapy was delivered within twomonths
from diagnosis after the child was infection free. A combination of 40mg/
kg/day of Horse derived antithymocyte globulin (ATGAM) and methyl-
prednisolone at 2 mg/kg/day were started for the ﬁrst 4 days through a
central venous catheter. Oral cyclosporine and G-CSF were started on the
ﬁfth day and since 2015 Eltrombopag was added to the IST regimen.
Revolade and GCSF were continued for about 8 to 12 weeks and cyclo-
sporine from 6 to 12 months. All patient received Voriconazole and
Acyclovir prophylaxis till neutrophil recovery to 1000.
Results: A total of 109 children had been diagnosed as AA, of whom, 42
had acquired AA. Themean age of childrenwith acquired AAwas 8.16 years
(2-15 yrs). Boys were twice more commonly affected (ratio M: F ¼ 2:1).
Details are listed in table 1.
Of the 41, 21 underwent HSCT as they had fully matched related donor and
20 children received IST. Of the 20 children who received ATG, 10 children
(70%) had complete remission in a median duration of 78 days. Two of the
three non responderswere treated with second IST and all three succumbed
to the illness. One child developed acute myeloid leukaemia after achieving
partial remission and was salvaged with HSCT, and 1 more non responder
had an unrelated HSCT and is doing well. One child has suffered a relapse
after a durable remission of over 18 months off immunosuppression. The 21
children who have been transplanted have an overall survival rate of 77 %.
Conclusion: Immunosuppressive regimen including Horse ATGAM,
Methyl prednisolone, Cyclosporine, GCSF and Eltrombopag along with
adequate and meticulous supportive care including neutropenic care,
prompt infection management and the use of irradiated and leukode-
pleted blood products results in a 70% response rate and should be offered
to all children with aplastic anaemia with no matched family donor. Theaddition of Elthrombopag has resulted in early recovery of all three cell
lines and must be added to the IST protocol in children.
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Introduction: Advances in blood banking has ensured optimal delivery of
monthly transfusion needed to save the lives of about 10,000 new thal-
assaemia children born each year in our country. The burden of iron che-
lation has now increased as these children survive into their second and
third decade of life. Cardiac failure secondary to myocardial haemoside-
rosis is the most common cause of mortality in these patients. Our study
has been done to evaluate the prevalence and severity of cardiac ironload
in children with beta thalassemia major and the effectiveness of serum
ferritin as a marker of iron overload.
Patients and Methods: We conducted a prospective study from the year
2015-2016 where we performed T2* cardiac magnetic resonance (CMR),
serum ferritin levels and pulmonary artery pressures by echocardiography
in 100 patients with transfusion dependent beta thalassaemia major. The
study had been approved by IRB at the VHS centre and informed consent
was obtained from all of these families. The median age of our patients was
14 (range 7 TO 33 years) with 51% of them being female. The mean serum
ferritin level was 2520.78 +-223.454 ng/ml. High iron overload with a
serum ferritin of over 2500 was seen in 37% of our patients. The 29% pa-
tient group that had less than 1000 ferritin were considered to be chelated
optimally as per international guidelines. A cardiac T2*of over 20 milli-
seconds was taken as a marker of heart free of iron overload.
The mean cardiac MRI T2* was 12.73 +-2.436 milliseconds. About 70% of
our patients had moderate myocardial iron overload (T2* 10-20 ms) and
24% had severe iron overload (T2* <10ms). The mean pulmonary arterial
pressure was 35.96+-8.3 mm of Hg. About 76% of the patients were on a
single drug chelation therapy at the time of evaluation. Following the
cardiac iron status they have been started on combination chelation
therapy consisting of deferasirox and deferiprone.
We found no signiﬁcant correlation (r¼0.014, p¼0.23) between the serum
ferritin levels and myocardial ironload. The most signiﬁcant ﬁnding was
that 38 % (11/29) of our patients with serum ferritin < 1000 had severe
cardiac iron load. A signiﬁcant correlation could also be established be-
tween pulmonary arterial pressures and cardiac MRI T2 *(r¼1.2, p
¼0.0024).
